Cargando…
MicroRNAs as a possible biomarker in the treatment of multiple sclerosis
Multiple sclerosis (MS) is a demyelinating, autoimmune and inflammatory disease that affects the central nervous system (CNS) and is one of the leading causes of disability in young adults worldwide. There are different drugs for the treatment of MS that aim to modify the natural course of the disea...
Autores principales: | Pérez, Moisés Manuel Gallardo, Eisele, Solón Javier Garcés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685387/ https://www.ncbi.nlm.nih.gov/pubmed/36439971 http://dx.doi.org/10.1016/j.ibneur.2022.11.001 |
Ejemplares similares
-
MicroRNAs and Multiple Sclerosis
por: Tufekci, Kemal Ugur, et al.
Publicado: (2010) -
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
por: Regev, Keren, et al.
Publicado: (2016) -
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
Publicado: (2016) -
MicroRNAs, Multiple Sclerosis, and Depression
por: Wang, Hsiuying
Publicado: (2021) -
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
por: Ricci, Claudia, et al.
Publicado: (2018)